These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3813869)

  • 1. Effect of altered volume of distribution on aminoglycoside levels in patients in surgical intensive care.
    Niemiec PW; Allo MD; Miller CF
    Arch Surg; 1987 Feb; 122(2):207-12. PubMed ID: 3813869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered aminoglycoside pharmacokinetics in the critically ill.
    Beckhouse MJ; Whyte IM; Byth PL; Napier JC; Smith AJ
    Anaesth Intensive Care; 1988 Nov; 16(4):418-22. PubMed ID: 3232800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminoglycoside Dosing and Volume of Distribution in Critically Ill Surgery Patients.
    Grucz TM; Kruer RM; Bernice F; Lipsett PA; Dorman T; Sugrue D; Jarrell AS
    Surg Infect (Larchmt); 2020 Dec; 21(10):859-864. PubMed ID: 32302517
    [No Abstract]   [Full Text] [Related]  

  • 4. Aminoglycosides in septic shock: an overview, with specific consideration given to their nephrotoxic risk.
    Boyer A; Gruson D; Bouchet S; Clouzeau B; Hoang-Nam B; Vargas F; Gilles H; Molimard M; Rogues AM; Moore N
    Drug Saf; 2013 Apr; 36(4):217-30. PubMed ID: 23508544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum level monitoring of aminoglycoside antibiotics. Limitations in intensive care unit-related bacterial pneumonia.
    Flint LM; Gott J; Short L; Richardson JD; Polk HC
    Arch Surg; 1985 Jan; 120(1):99-103. PubMed ID: 3966875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gentamicin volume of distribution in critically ill septic patients.
    Triginer C; Izquierdo I; Fernández R; Rello J; Torrent J; Benito S; Net A
    Intensive Care Med; 1990; 16(5):303-6. PubMed ID: 2212254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial aminoglycoside levels in the critically ill.
    Summer WR; Michael JR; Lipsky JJ
    Crit Care Med; 1983 Dec; 11(12):948-50. PubMed ID: 6641254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aminoglycoside dosing considerations in intensive care unit patients.
    Watling SM; Dasta JF
    Ann Pharmacother; 1993 Mar; 27(3):351-7. PubMed ID: 8267695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminoglycoside volume of distribution in pediatric patients.
    Shevchuk YM; Taylor DM
    DICP; 1990 Mar; 24(3):273-6. PubMed ID: 2316235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of extended-interval aminoglycoside dosing strategies for the treatment of moderate-to-severe infections encountered in critically ill surgical patients.
    Mueller EW; Boucher BA
    Surg Infect (Larchmt); 2009 Dec; 10(6):563-70. PubMed ID: 20035611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of antibiotics in critically ill patients.
    van Dalen R; Vree TB
    Intensive Care Med; 1990; 16 Suppl 3():S235-8. PubMed ID: 2289997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of patients treated by an aminoglycoside pharmacokinetic dosing service.
    Sveska KJ; Roffe BD; Solomon DK; Hoffmann RP
    Am J Hosp Pharm; 1985 Nov; 42(11):2472-8. PubMed ID: 4073064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of altered aminoglycoside volume of distribution on the adequacy of a three milligram per kilogram loading dose. Critical Care Research Group.
    Dorman T; Swoboda S; Zarfeshenfard F; Trentler B; Lipsett PA
    Surgery; 1998 Jul; 124(1):73-8. PubMed ID: 9663254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic absorption of endotracheally administered aminoglycosides in seriously ill patients with pneumonia.
    Crosby SS; Edwards WA; Brennan C; Dellinger EP; Bauer LA
    Antimicrob Agents Chemother; 1987 Jun; 31(6):850-3. PubMed ID: 3619417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-dose pharmacokinetics of aminoglycosides in critically ill haematological malignancy patients.
    Blackburn LM; Tverdek FP; Hernandez M; Bruno JJ
    Int J Antimicrob Agents; 2015 Jan; 45(1):46-53. PubMed ID: 25455848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of pharmacokinetic indices with therapeutic outcome in patients receiving aminoglycosides.
    Deziel-Evans LM; Murphy JE; Job ML
    Clin Pharm; 1986 Apr; 5(4):319-24. PubMed ID: 3709080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of sepsis on higher daily dose of amikacin pharmacokinetics in critically ill patients.
    Mahmoudi L; Mohammadpour AH; Ahmadi A; Niknam R; Mojtahedzadeh M
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17(3):285-91. PubMed ID: 23426530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased aminoglycoside dosage requirements in hematologic malignancy.
    Zeitany RG; El Saghir NS; Santhosh-Kumar CR; Sigmon MA
    Antimicrob Agents Chemother; 1990 May; 34(5):702-8. PubMed ID: 2360811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic exposure to aminoglycosides following knee and hip arthroplasty with aminoglycoside-loaded bone cement implants.
    Kalil GZ; Ernst EJ; Johnson SJ; Johannsson B; Polgreen PM; Bertolatus JA; Clark CR
    Ann Pharmacother; 2012; 46(7-8):929-34. PubMed ID: 22764326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.